抗菌药物使用、耐药菌感染与新冠病毒。
Antimicrobial use, drug-resistant infections and COVID-19.
机构信息
Imperial College London, South Kensington, London, UK.
出版信息
Nat Rev Microbiol. 2020 Aug;18(8):409-410. doi: 10.1038/s41579-020-0395-y.
Abstract
Coronavirus disease 2019 may have a complex long-term impact on antimicrobial resistance (AMR). Coordinated strategies at the individual, health-care and policy levels are urgently required to inform necessary actions to reduce the potential longer-term impact on AMR and on access to effective antimicrobials.
摘要
2019 年冠状病毒病可能对抗菌药物耐药性（AMR）产生复杂的长期影响。迫切需要在个人、医疗保健和政策层面采取协调一致的策略，为减少对 AMR 以及对有效抗菌药物的可及性的潜在长期影响而采取必要行动提供信息。
相似文献
1
Antimicrobial use, drug-resistant infections and COVID-19.
Nat Rev Microbiol. 2020 Aug;18(8):409-410. doi: 10.1038/s41579-020-0395-y.
2
Antimicrobial stewardship: a COVID casualty?
J Hosp Infect. 2020 Nov;106(3):401-403. doi: 10.1016/j.jhin.2020.10.002. Epub 2020 Oct 9.
3
COVID-19 will further exacerbate global antimicrobial resistance.
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
4
Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern.
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1371-1372. doi: 10.1017/ice.2020.381. Epub 2020 Jul 30.
5
COVID-19: don't neglect antimicrobial stewardship principles!
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
6
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
7
Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
J Infect. 2020 Sep;81(3):e29-e30. doi: 10.1016/j.jinf.2020.06.077. Epub 2020 Jul 3.
8
Could the COVID-19 pandemic aggravate antimicrobial resistance?
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
9
Bacterial coinfections in COVID-19: an underestimated adversary.
Ann Ist Super Sanita. 2020 Jul-Sep;56(3):359-364. doi: 10.4415/ANN_20_03_14.
10
Optical theranostics and treatment dosimetry for COVID-19 lung complications: Towards increasing the survival rate of vulnerable populations.
Photodiagnosis Photodyn Ther. 2020 Sep;31:101892. doi: 10.1016/j.pdpdt.2020.101892. Epub 2020 Jun 22.
引用本文的文献
1
Optimization and Characterization of Bioactive Metabolites from Cave-Derived C1.
Biomolecules. 2025 Jul 24;15(8):1071. doi: 10.3390/biom15081071.
2
Carbapenem-Resistant Gram-Negative Bacteria in Hospitalized Patients: A Five-Year Surveillance in Italy.
Infect Dis Rep. 2025 Jul 2;17(4):76. doi: 10.3390/idr17040076.
3
Editorial: Evolution, molecular mechanisms and the strategies to combat antimicrobial resistance (AMR): a One Health approach.
Front Cell Infect Microbiol. 2025 Jun 2;15:1582613. doi: 10.3389/fcimb.2025.1582613. eCollection 2025.
4
An undergraduate experimental research program, involving the screening of efflux pump inhibitors, to improve student research skills in biomedical science.
BMC Med Educ. 2025 May 26;25(1):770. doi: 10.1186/s12909-025-07340-2.
5
Targeting USP22 to promote K63-linked ubiquitination and degradation of SARS-CoV-2 nucleocapsid protein.
J Virol. 2025 May 20;99(5):e0223424. doi: 10.1128/jvi.02234-24. Epub 2025 Apr 4.
6
The impact of the COVID-19 pandemic on antimicrobial usage: an international patient-level cohort study.
JAC Antimicrob Resist. 2025 Mar 26;7(2):dlaf037. doi: 10.1093/jacamr/dlaf037. eCollection 2025 Apr.
7
Addressing the challenge of antimicrobial resistance.
Commun Med (Lond). 2025 Mar 6;5(1):67. doi: 10.1038/s43856-025-00758-1.
8
National trends in Azithromycin consumption during 2017-2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines.
Sci Rep. 2025 Feb 21;15(1):6309. doi: 10.1038/s41598-025-91216-4.
9
Antibacterial Polymers Based on Two Orthogonal Binding Motifs Coalesce with Bacterial Matter.
ACS Appl Bio Mater. 2025 Mar 17;8(3):2377-2385. doi: 10.1021/acsabm.4c01872. Epub 2025 Feb 20.
10
A Six Years' Trend Analysis of Antimicrobial Resistance Among Bacterial Isolates at Public Health Institute in Amhara Region, Ethiopia.
Biomed Res Int. 2025 Jan 29;2025:7676973. doi: 10.1155/bmri/7676973. eCollection 2025.
本文引用的文献
1
Reply to Dudoignon et al.
Clin Infect Dis. 2021 Mar 1;72(5):906-908. doi: 10.1093/cid/ciaa767.
2
COVID-19 and the potential long-term impact on antimicrobial resistance.
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
Zotero 插件